Mednet Logo
CommunityHospital Medicine

How do you approach low to moderate titer of APLS when working up unprovoked DVT if it is persistent on repeat testing?

Community PollStarted

How do you approach persistent low titers of antiphospholipid antibodies found in unprovoked DVT?

68 physicians have voted

Join Mednetto vote and see how they answered.

4 Answers
Mednet Member
Mednet MemberInvited Expert
Hematology · University of Maryland
Answered on

I have a low threshold to recommend long term (indefinite) anticoagulation for unprovoked thrombosis, regardless of whether there is positive APLS testing. I do agree with Dr. @Dr. First Last, however, that shared decision-making is important when committing a patient to prolonged anticoagulation, a...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Rheumatology · Hackensack University Medical Center
Answered on

In the absence of strong evidence or guidelines, this would be a case-by-case decision. I would probably be inclined not to anticoagulate indefinitely, however, shared decision making with the patient is key.
Several variables to consider would be other traditional risk factors, the presence of other...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Rheumatology · UTMB Health
Answered on

If the patient already had an unprovoked DVT, and has had persistently low to moderate titers of APL antibodies, I think you need to consider some type of therapeutic intervention. At the very least, even though the evidence is not strong in the medical literature, I would consider using HCQ, stoppi...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Mary Lanning Healthcare Morrison Cancer Center/University of Nebraska Medical Center Adjunct Faculty
Answered on

Classifying the aPL profile as high- or low-risk, in conjunction with concomitant risk factors, can provide a general estimate of risk. Aspirin is recommended for primary prevention in individuals who have SLE and aPL, or in those without SLE but who have a high-risk profile.

For patients who have AP...

Join for free or sign in to see the full answer